Sugi Predict

Sugi Predict / Compounds / SCHEMBL6030205

SCHEMBL6030205

SCHEMBL6030205

CCCCCCCCNC(=O)Nc1sc(C(=O)N(CC)OC)c(C)c1C(=O)O

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 9/20 0.46
▸ NPSR1 Q6W5P4 3/20 0.46
▸ HPGD P15428 3/20 0.46
▸ MAPT P10636 2/20 0.46
▸ APOBEC3G Q9HC16 1/20 0.46
▸ TSHR P16473 2/20 0.40
▸ HSD17B10 Q99714 2/20 0.40
▸ DUSP3 P51452 1/20 0.40
▸ PTPN5 P54829 1/20 0.40
▸ PTPN11 Q06124 1/20 0.40
▸ SMN1; SMN2 Q16637 1/20 0.40
▸ EPHX1 P07099 10/20 0.39
▸ HTT P42858 1/20 0.39
▸ LMNA P02545 1/20 0.39
▸ MAPK1 P28482 1/20 0.39
▸ MEN1 O00255 1/20 0.37
▸ KMT2A Q03164 1/20 0.37
▸ CYP1A2 P05177 1/20 0.37
▸ CYP2C9 P11712 1/20 0.37
▸ CYP2C19 P33261 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6029976 0.87 ALDH1A1 (0.47) ALDH1A1NPSR1HPGDMAPTAPOBEC3G
SCHEMBL6030364 0.86 EPHX1 (0.45) ALDH1A1NPSR1HPGDMAPTAPOBEC3G
SCHEMBL6030355 0.86 ALDH1A1 (0.48) ALDH1A1NPSR1HPGDMAPTAPOBEC3G
SCHEMBL6030772 0.84 EPHX1 (0.46) ALDH1A1NPSR1HPGDMAPTAPOBEC3G
SCHEMBL6030371 0.84 EPHX1 (0.46) ALDH1A1NPSR1HPGDMAPTAPOBEC3G
SCHEMBL6030406 0.84 EPHX1 (0.46) ALDH1A1NPSR1HPGDMAPTAPOBEC3G
SCHEMBL6030269 0.84 EPHX1 (0.46) ALDH1A1NPSR1HPGDMAPTAPOBEC3G
SCHEMBL6030458 0.84 EPHX1 (0.48) ALDH1A1NPSR1HPGDMAPTAPOBEC3G
SCHEMBL6030199 0.83 EPHX1 (0.41) ALDH1A1NPSR1HPGDMAPTAPOBEC3G
SCHEMBL6030430 0.83 EPHX1 (0.41) ALDH1A1NPSR1HPGDMAPTAPOBEC3G

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7064122-B2 Pancreatic lipase inhibitor compounds, their synthesis and use OSI PHARMACEUTICALS, INC. (US) 2006-06-20 — — US disclosed
EP-1467978-A4 PANCREATIC LIPASE INHIBITOR COMPOUNDS, THEIR SYNTHESIS AND USE OSI PHARM INC (US) 2005-11-02 — — EP disclosed
EP-1467978-A1 PANCREATIC LIPASE INHIBITOR COMPOUNDS, THEIR SYNTHESIS AND USE OSI Pharmaceuticals, Inc. (US) 2004-10-20 — — EP disclosed
US-20030195199-A1 Pancreatic lipase inhibitor compounds, their synthesis and use OSI PHARMACEUTICALS, INC. 2003-10-16 — — US disclosed
WO-2003053944-A1 PANCREATIC LIPASE INHIBITOR COMPOUNDS, THEIR SYNTHESIS AND USE OSI PHARMACEUTICALS, INC. (US) 2003-07-03 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030195199-A1 Pancreatic lipase inhibitor compounds, their synthesis and use PNLIP, LIPC, CEL ALDH1A1 1832/4885NPSR1 393/4885HPGD 4273/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.